Gabapentin
Product Images NDC 64725-0511

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64725-0511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0511)

This is a description of a medication called Gabapentin in a 100mg capsule form, which is sold in a bottle containing 100 capsules. The medication is only available by prescription (Rx). The product is manufactured by a company called Actavis, and it was packaged by 7Y.A. Pharmaceuticals. The address and phone number of the packaging company are provided. The lot number is listed as '00,' and the expiration date is not specified. The dose information is not available in this text.*

FDA Label Image

0e023a94-figure-01 (Gabapentin Capsule 1)

FDA Label Image

0e023a94-figure-02 (Gabapentin Capsule 2)

This text represents a graph or chart with a 4-week dose titration period and a 4-week fixed dose period, where the doses of placebo and Gabapentin (at 1800mg and 2400mg per day) are compared. The graph shows a significant improvement in symptoms with Gabapentin compared to placebo, as indicated by the p-value of less than 0.001. There is no additional information available from this text.*

FDA Label Image

0e023a94-figure-03 (Gabapentin Capsule 3)

The text is not available for evaluation as it just shows some numerical values and an acronym PBO, without any context or further information.*

FDA Label Image

0e023a94-figure-04 (Gabapentin Capsule 4)

FDA Label Image

0e023a94-figure-05 (Gabapentin Capsule 5)

The text shows a chart with a Mean Pain Score. There are two periods indicated, one with a Dose Tiration and another with a Fixed Dose. The chart also shows results for a Placebo and for Gabapentin (at a dose of 3600 mg/day) for a total of eight weeks.*

FDA Label Image

0e023a94-figure-06 (Gabapentin Capsule 6)

FDA Label Image

0e023a94-figure-07 (Gabapentin Capsule 7)

FDA Label Image

0e023a94-figure-08 (Gabapentin Capsule 8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.